Graduates from the Human Genetics program pursue careers in academia, medicine, industry, teaching, government, law, as well the private sector. Our trainees are encouraged to explore the full spectrum of professional venues in which their training my provide a strong foundation. Driven by curiosity and a desire for excellence, our trainees stand out as leaders in the chosen arenas of professional life. They are supported in the development of their career plans by a program faculty and administration who are dedicated to their success, and by a myriad of support networks across the Johns Hopkins University, many of which are provided by the Professional Development Career Office of the School of Medicine.
General info.
Amanda Shipp Program Coordinator Graduate Program in Genetics and Genomics Box 103855 Duke University Medical Center Durham, NC 27710
Email: [email protected]
Website: http://upg.duke.edu
The program provides a unified curriculum of study in genetics and genomics leading to the Ph.D. Areas of specialization include population and evolutionary genetics, microbial and viral genetics, human and mammalian genetics, developmental genetics, epigenomics, and plant genetics. This is an interdisciplinary program with faculty drawn from several departments (Biochemistry, Biology, Cell Biology, Chemistry, Molecular Genetics and Microbiology, Immunology, Neurobiology, Pathology and Pharmacology and Cancer Biology) as well as from the Institute of Molecular Physiology.
Application Terms Available: Fall
Application Deadline: December 2
Graduate School Application Requirements See the Application Instructions page for important details about each Graduate School requirement.
Department-Specific Application Requirements (submitted through online application)
Writing Sample None required
Additional Components Optional Video Essay: How would a Duke PhD training experience help you achieve your academic and professional goals? Max video length 2 minutes; record externally and provide URL in application.
We strongly encourage you to review additional department-specific application guidance from the program to which you are applying: Departmental Application Guidance
List of Graduate School Programs and Degrees
INFORMATION FOR
Additional responsibilities, md/phd studies, admission & financial aid.
The program of study leading to the PhD degree emphasizes a broad approach to the fundamental principles of genetics, development and molecular biology combined with extensive research training. The program is designed to permit close interaction between graduate students, postdoctoral fellows, and faculty, while also encouraging full participation in the larger community of biological scientists at Yale.
The PhD program in Genetics is designed to provide the student with a broad background in general genetics and the opportunity to conduct original research in a specific area of genetics. The Genetics student is expected to acquire a broad understanding of genetics, spanning knowledge of at least three basic areas of genetics, which include molecular, cellular, organismal, and population genetics. Normally this requirement is accomplished through the satisfactory completion of formal courses, many of which cover more than one of these areas. Students are required to pass at least six graduate level courses.
Students enter the Genetic Graduate Program following the completion of their first year of studies within the BBS Program. Students who enter the Genetics Graduate Program normally select a faculty thesis advisor with an appointment in the Department of Genetics. Read more about our research labs here . Advanced graduate study becomes increasingly focused on the successful completion of original research and the preparation of a written dissertation under the direct supervision of a faculty advisor along with the guidance of a thesis committee.
A qualifying examination is given during the second year of study. This examination consists of a period of directed reading with the faculty followed by the submission of two written proposals and an oral examination. Following the completion of course work and the qualifying examination, the student submits a dissertation prospectus (by the end of the sixth term) and is admitted to candidacy for the PhD degree. There is no language requirement.
The completed research is presented in the form of a written dissertation and a formal seminar. Typically four to six years are required in total to complete work for the PhD degree.
An important aspect of graduate training in genetics is the acquisition of communication and teaching skills. Students participate in presentation seminars and are asked to serve as teaching assistants during two terms (or the equivalent). Teaching duties normally involve assisting in discussion sections, seminar groups or laboratories, and grading, and do not require more than 10 hours per week. Teaching activities are drawn from a diverse menu of lecture, laboratory, and seminar courses given at the undergraduate, graduate, and medical school level. Students are not expected to teach during their first year.
Exchange of information with colleagues is an essential component of scientific life. The Genetics Department hosts a Genetics Journal Club as well as a weekly seminar series. Advanced graduate students present the results of their research to members of the Department in a Research in Progress series each year.
The annual departmental retreat consists of a weekend program of informal research talks, poster sessions, and discussions. This provides an outstanding opportunity to keep up-to-date with the diverse research underway in the department and to participate in vigorous scientific discussions. In addition to these intradepartmental activities, there are many additional seminar programs in which outside speakers from the U.S. and abroad present their work to the Yale scientific community. Students have the opportunity to meet with these guests as well as to select and host seminar speakers. Students are also encouraged to travel to scientific meetings and to present their research.
The breadth of the Program, the flexible nature of its graduate studies, and the increasing recognition of the importance of genetics and development in medicine make this Program ideal for MD/PhD students who wish to pursue a career combining basic and clinical research. Interested students should contact:
Kayla McKay , Registrar, MD/PhD Program Yale School of Medicine 367 Cedar St. New Haven, CT 06510-8046 Tel. 203.785.4403
All the resources for genetic and molecular biology research are available at the University. Major items include the Biomedical Computing Unit, nucleotide and peptide synthesis and sequencing, high throughput microarray technology for functional genomic and proteomic analysis, and facilities for electron microscopy, laser scanning, confocal microscopy, and transgenic mouse and hybridoma construction.
Research laboratories are located throughout the Yale University campus. The Departments of Cell Biology, Genetics, Immunobiology, Microbial Pathogenesis, Neurobiology, Pathology and a portion of Molecular Biophysics & Biochemistry are located in the School of Medicine, while the Molecular, Cellular & Developmental Biology Department, Computational Biology & Bioinformatics, Ecology and Evolutionary Biology, and the balance of Molecular Biophysics & Biochemistry are in the Science Hill area of Yale College.
Research in the biological and biomedical sciences has become increasingly integrated between Yale’s campuses and departments. Research laboratories are located both in the School of Medicine and in the Science Hill area of Yale College. The Molecular Biophysics & Biochemistry Department, as well as interdepartmental programs in Neurobiology and Computational Biology and Bioinformatics, have branches in both campuses. The School of Medicine and Science Hill are within walking and bicycling-distance, and a free shuttle bus operates daily to provide transportation between these sites.
Three newly constructed buildings and renovated spaces have added state-of-the-art facilities to the Yale campus. The Boyer Center for Molecular Medicine at the School of Medicine helps bring together both basic and clinical scientists in areas such as molecular genetics, molecular oncology and development, and molecular neurobiology. The new Anlyan Center for Medical Research and Education houses laboratory space, the new Magnetic Resonance Research Center, the Section of Bioimaging sciences, modern teaching facilities and new animal care facilities. The Nancy Lee and Perry R. Bass Center for Molecular and Structural Biology provides a state-of-the-art teaching and research facility that brings together researchers from throughout the University to study gene expression and protein structure. This four-story structure on Science Hill is linked via bridges to the Sterling Chemistry Laboratory and the Josiah Willard Gibbs Research Laboratory. The Yale Center for Genome Analysis (YCGA) is a state-of-the-art DNA Sequencing Center Launched in 2010 on Yale's West Campus to provide a centralized facility for services, equipment and expertise required for carrying out large-scale sequence analysis studies. Yale has allocated entire building to YCGA with over 7000 sq. ft. of custom-designed laboratory and office space equipped with all modern amenities.
Admission to the Department of Genetics graduate program is through an interest-based track, usually the Molecular Cell Biology, Genetics & Development Track (MCGD) in the Combined Program in the Biological and Biomedical Sciences (BBS) . Appropriate preparation for graduate study in Genetics includes a bachelor’s degree in the natural sciences including course work in biology, chemistry, and mathematics. Almost all successful applicants have undergraduate or postgraduate research experience and have completed courses in genetics, biochemistry, or molecular and cell biology.
Approximately 25 new students enter the Molecular Cell Biology, Genetics and Development Track (MCGD) Track each year. Admission is competitive and is based on evaluation by an admissions committee of academic performance, potential, and letters of recommendation. The top applicants are invited to New Haven at the program's expense for a day of introduction and interviews to assist in the admissions decision.
Students accepted into our graduate program receive a full tuition scholarship including health coverage and a yearly allotment for travel to scientific meetings. All students also receive a stipend for living expenses for the duration of their graduate studies. In most cases, tuition and stipend funds are from predoctoral training grants awarded to Yale by the National Institutes of Health.
Financial aid from international students is extremely competitive and is arranged on an individual basis. International applicants are strongly urged to apply for scholarships or funding from their government or other agencies. Prospective students should submit a completed application form (download application forms), transcripts, graduate records exam scores, and letters of recommendation to the Office of Graduate Admissions by that date. International applicants are also required to submit scores on the Test of English as a Foreign Language (TOEFL). Applications and further information may be obtained by contacting the Office of Graduate Admissions:
Office of Graduate Admissions Yale University PO Box 208323 New Haven, CT 06520-8323 USA
Furthering our understanding of biology and human disease
The Department of Human Genetics at the University of Michigan was founded by Dr. James V. Neel in 1956 and was the first human genetics department in the United States. The initial focus of the department was human heredity, and this view has grown in breadth and depth through the genomic and post-genomic eras.
Our faculty include AAAS, National Academy and Institute of Medicine Fellows, Howard Hughes Investigators, and winners of University and Medical School teaching awards. Interactions among students and faculty ensure a comprehensive foundation in the many aspects of genetics, from genome function, to population diversity and the molecular mechanisms of disease. Collaborations within the department, across the University, nation-wide and internationally emphasize the crucial role of genetics in addressing global problems in human biology and disease.
A central mission of the Genetics and Genomics Graduate Program is to train students to confront these problems scientifically through a rigorous but flexible foundation in coursework and research.
Apply through our PIBS application
Graduate students have the opportunity to carry out interdisciplinary genetics research in diverse areas.
Examples of current research topics include:
The multidisciplinary nature of this research is demonstrated by strong faculty involvement in the Genetics Training Program and Genome Science Training Grants, which are both supported by the NIH for 40 and 25 years, respectively. The Genetics Training Program is directed from the Department of Human Genetics, with faculty and student participation from five other PhD programs. The Genome Science Training Grant is co led by HG, with faculty and student participation from eight other PhD programs across the University of Michigan campus.
Genetics and Genomics students and faculty also participate in training programs in Bioinformatics; Cancer Biology; Genome Sciences; Organogenesis; Reproductive Biology; and Hearing, Balance, and Chemical Senses.
The core training in Genetics and Genomics consists of courses in molecular genetics, the genetic basis of human disease, and quantitative and statistical genetics. Additional courses are selected from within the Department of Human Genetics and throughout the University to strengthen one or more core areas. Coursework is designed to meet the individual training goals of students in the Program.
In addition to the core courses, students participate in the weekly student seminars, in which they learn to analyze and present research literature before the greater genetics community, including faculty and students. In the second year, students take Current Topics, a small class that focuses on current methods in genetic research through discussions of selected primary scientific literature, with student-led presentations.
The interactive and interdisciplinary nature of Genetics and Genomics is also highlighted by Departmental and training program seminars on cutting-edge topics presented by high-profile outside speakers, some of whom are selected by the students.
Students take a preliminary examination during the Summer after their first year. The exam is a written and oral defense of the student’s proposed thesis research. Students advance to candidacy once they have passed the preliminary examination, completed certain course requirements, and received the approval of their thesis research mentor.
While teaching is not a Program requirement, most Genetics and Genomics students spend at least one term as a teaching assistant, generally in their second or third year. Additional teaching opportunities are available through several outreach programs.
After completion of required coursework, the doctoral dissertation is generally completed within 5 years of graduate study; however, this varies among students.
The Department of Human Genetics includes more than 21 Genetics and Genomics PhD students, as well as 27 primary faculty and 16 joint faculty whose primary appointments represent six additional departments. Up to eight students join our program each year and the Department is in an active growth phase with faculty added over the last few years and more recruitment planned.
Our students have received national fellowships and awards for their research, have served on national committees including in the American Society of Human Genetics, and have been recognized with the University of Michigan Distinguished Dissertation Award , the highest honor the University confers to recognize graduate student accomplishments.
Students get to know faculty and their research through numerous events throughout the year, including the Department retreat, Genetics and Genomics Retreat, the James V. Neel Lectureship, and the Thomas D. Gelehrter Lectureship. The Department of Human Genetics sponsors a seminar series of external speakers, short courses with several speakers on a related theme, and a weekly seminar given by trainees in the Department. There are also a variety of informal special interest groups that offer opportunities for students to present and get advice on their research findings.
Over 180 Genetics and Genomics PhD graduates have gone on to successful careers in academic research and teaching, biotechnology, and scientific consulting, among other professions.
Learn more about the Department of Genetics and Genomics.
We transform lives through bold discovery, compassionate care and innovative education.
We're sorry but you will need to enable Javascript to access all of the features of this site.
Genetics and genomics program.
Stanford School of Medicine , Stanford Center for Health Education
Get Started
Thank you for your interest in the Stanford Genetics and Genomics Program!
We are now offering two new programs: Foundations of Genetics and Genomics and Advanced Topics in Genetics and Genomics.
New technologies and breakthroughs in research are impacting the health and medicine industries and allowing for the use of personalized medicine, genetic engineering, and more. But what does this all mean, and how are these innovations occurring? Understanding the core concepts of genes and genomes will help you grasp how researchers and health professionals improve disease diagnosis, prevention, and treatment. From studying the function and structure of chromosomes to examining the genetic codes found in DNA, the Foundations of Genetics and Genomics track will give you the fundamental knowledge needed to understand how we can progress in our work targeting human health and disease and prepare you to explore more advanced topics.
Advanced Topics in Genetics and Genomics
Technologies like CRISPR and stem cell therapies, and research such as those in the fields of epigenetics and biotechnology, are changing how we understand and develop solutions for medicine, biology, and agriculture. The fields of genetics and genomics are constantly evolving from personalized treatment plans based on your genes, lifestyle, and environment to manipulating DNA and editing genetic code. The Advanced Topics in Genetics and Genomics track allows you to dive deeper into the topics you care about and provides you with up-to-date information on cutting-edge research and technologies in the health and medicine industries today.
Advanced topics in genetics and genomics.
Teaching team.
Kenneth Fong Professor
Bioengineering
Russ Biagio Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing and informatics technologies to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. His lab studies how human genetic variation impacts drug response (e.g., http://www.pharmgkb.org/). Other work focuses on the analysis of biological molecules to understand the actions, interactions and adverse events of drugs (e.g., http://feature.stanford.edu/). He helps lead an FDA-supported Center of Excellence in Regulatory Science & Innovation.
Dr. Altman holds an AB from Harvard College, and an MD from Stanford Medical School, and a PhD in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians (ACP), the American College of Medical Informatics (ACMI), the American Institute of Medical and Biological Engineering (AIMBE), and the American Association for the Advancement of Science (AAAS). He is a member of the National Academy of Medicine (formerly the Institute of Medicine, IOM). He is a past-president, founding board member, and a fellow of the International Society for Computational Biology (ISCB), and a past-president of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). He has chaired the Science Board advising the FDA commissioner, served on the NIH Director’s Advisory Committee, and co-chaired the IOM Drug Forum. He is an organizer of the annual Pacific Symposium on Biocomputing, and a founder of Personalis, Inc. Dr. Altman is board certified in Internal Medicine and in Clinical Informatics. He received the Stanford Medical School graduate teaching award in 2000 and mentorship award in 2014.
Licensing Associate
Stanford University
Ximena Ares is a Licensing Associate at the Stanford Office of Technology Licensing (OTL). Dr. Ares received her Ph.D training in Molecular Biology in Buenos Aires, Argentina and completed her postdoctoral training at the University of California, San Francisco in Human Genetics. Later, she was a scientist at Geron Corporation and a Research Fellow at the Molecular Sciences Institute in Berkeley, California. She joined Stanford OTL in 2004, where she manages a portfolio of about 250 life sciences inventions, makes decisions about their intellectual property protection and negotiates license agreements and other contracts.
Roger and Joelle Burnell Professor
Born and raised in Scotland, Euan Angus Ashley graduated with 1st class Honors in Physiology and Medicine from the University of Glasgow. He completed medical residency and a PhD in molecular cardiology at the University of Oxford before moving to Stanford University where he trained in cardiology and advanced heart failure joining the faculty in 2006. His group is focused on the application of genomics to medicine. In 2010, he led the team that carried out the first clinical interpretation of a human genome. The paper published in the Lancet was the focus of over 300 news stories, became one of the most cited articles in clinical medicine that year, and was featured in the Genome Exhibition at the Smithsonian in DC. The team extended the approach in 2011 to a family of four and now routinely apply genome sequencing to the diagnosis of patients at Stanford hospital where Dr Ashley directs the Clinical Genome Service and the Center for Inherited Cardiovascular Disease. In 2013, Dr Ashley was recognized by the White House Office of Science and Technology Policy for his contributions to Personalized Medicine. In 2014, Dr Ashley became co-chair of the steering committee for the NIH Undiagnosed Diseases Network. Dr Ashley is a recipient of the National Innovation Award from the American Heart Association (AHA) and a National Institutes of Health (NIH) Director’s New Innovator Award. He is a member of the AHA Council on Functional Genomics, and the Institute of Medicine (IOM) of the National Academy of Sciences Roundtable on Translating Genomic-Based Research for Health. He is a peer reviewer for the NIH and the AHA as well as journals including Nature, the New England Journal of Medicine, the Lancet and the Journal of Clinical Investigation. He is co-founder of Personalis Inc, a genome scale genetic diagnostics company. Father to three young Americans, in his ‘spare’ time, he tries to understand American football, plays the saxophone, and conducts research on the health benefits of single malt Scotch whisky.
Catharine and Howard Avery Professor
Academic Appointments
Israeli Society of Gene and Cell Therapy
Administrative Appointments
Founder of LogicBio Therapeutics, a gene therapy company (2014) Member of the American Society of Gene and Cell therapy (2011)
Honors & Awards
Presidential symposium lecturer at the annual meeting of the American Society for Gene and Cell Therapy (ASGCT) (2014) Recipient of the Child Health Research Institute (CHRI) fellowship (2013) 1st place- Stanford Genetics Department “Big Idea” Contest (2012)
Professional Education
MSc, Tel Aviv University, Tel Aviv, Israel, Genetics (2006) PhD, Tel Aviv University, Tel Aviv, Israel, Genetics (2011) Postdoctoral fellow, Stanford University (2011)
Associate Professor, Genetics
Senior Scientific Researcher
Chris Bjornson holds a Ph.D. from the University of Washington and has served as a Research Associate for Calos Lab, Stanford University.
Michele And Timothy Barakett Endowed Professor
Anne Brunet is a Professor of Genetics at Stanford University. Dr. Brunet is interested in the molecular mechanisms of aging and longevity, with a particular emphasis on the nervous system. Her lab is interested in identifying pathways involved in delaying aging in response to external stimuli such as availability of nutrients and mates. She also seeks to understand the mechanisms that influence the rejuvenation of old stem cells. Finally, her lab has pioneered the naturally short-lived African killifish as a new model to explore the regulation of aging and age-related diseases.
Senior Scientist, Population Genetics
Katarzyna ("Kasia") Bryc is a Senior Scientist of Population Geneticist at 23andMe. Dr. Bryc has developed statistical models that leverage genetic data to learn about ancient human history and migrations, recent population admixture and other forces shaping the human genome. Her prior research illuminated the genetic population structure of Africans, and the complex admixture of African Americans and Hispanic/Latino populations. Dr. Bryc received a B.A. from Stanford University, and her M.S. and Ph.D. in Biometry at Cornell under Dr. Carlos Bustamante. Prior to joining 23andMe, she was a NIH Ruth L. Kirschstein National Research Fellow at Harvard Medical School with Dr. David Reich, where she developed statistical methods to infer genetic diversity from sequence data.
Professor, Genetics (Emerita)
Professor, Genetics
Member, Bio-X
Member, Child Health Research Institute
Chair, School of Medicine Appointments and Promotions Committee (2008 - 2010)
Community and International Work
Associate Professor, Microbiology and Immunology
Professor, Pediatrics and Medicine
Senior Principle Scientific Researcher
Dr. Emily Crane grew up in Palo Alto, California. She left the sunshine state to earn her B.A. in Biology from Carleton College in Northfield, Minnesota. She returned to California in 2005, where she enrolled in graduate school at UC Berkeley and began training as a geneticist with Dr. Barbara Meyer. She studied the connection between gene expression regulation and chromosome structure, earning a Ph.D. in Molecular and Cell Biology in 2011. While pursuing her doctorate she was able to first pair research with teaching as a Graduate Student Instructor for both lab and lecture courses. She is currently a NIH IRACDA postdoctoral fellow at Stanford University, which allows her to do research while also teaching as a visiting professor at San Jose State University. At Stanford she works in Dr. Jin Li’s lab, where she is currently setting up a screening system to look for regulators of RNA editing. Dysregulation of RNA editing has been linked to neurological diseases and cancers, and its complete loss is lethal. Emily is passionate about the rapidly expanding field of personal genomics, which will soon be an indispensable resource for improving patient health.
Professor, Genetics and Biomedical Data Science
The Curtis laboratory couples innovative experimental approaches, high-throughput omic technologies, statistical inference and computational modeling to interrogate the evolutionary dynamics of tumor progression and therapeutic resistance. To this end, Dr. Curtis and her team have developed an integrated experimental and computational framework to measure clinically relevant patient-specific parameters and to measure clonal dynamics. Her research also aims to develop a systematic interpretation of genotype/phenotype associations in cancer by leveraging state-of-the-art technologies and robust data integration techniques. For example, using integrative statistical approaches to mine multiple data types she lead a seminal study that redefined the molecular map of breast cancer, revealing novel subgroups with distinct clinical outcomes and subtype-specific drivers.
Final Foods Inc.
Barbara Dunn is a Senior Biocuration Research Scientist in the Department of Genetics at Stanford University, currently working with the Saccharomyces Genome Database in the laboratory of Dr. J. Michael Cherry. She received her A.B. in Botany at Berkeley, and her Ph.D. in Biological Chemistry at Harvard University, where she studied yeast telomeres in the laboratory of Dr. Jack Szostak. Her recent research has focused on using whole-genome DNA and RNA sequencing, ChIP-Seq, array-CGH, and other “omics” methods to broadly explore evolution in yeast, and particularly the genome structures and genome evolution of industrial yeasts (lager, ale, wine, ethanol, bread).
Senior Scientific Curator
Dianna received her B.S. in Biology from Marquette University and her Ph.D. in Molecular Biology, Cell Biology and Genetics from the University of Oregon, where she studied how nuclear and chromosomal gene expression are coordinately regulated, in the laboratory of Dr. Alice Barkan. She then went on to work as a Scientific Curator under Dr. David Botstein and Dr. J. Michael Cherry, at the Saccharomyces Genome Database (SGD). After 13 years of analyzing, assembling and organizing the vast amounts of detailed biochemical and genetic data available on yeast, she switched to interpretation of human genomics data and is now the Senior Biocurator at the Stanford Clinical Genomics Service.
Professor, Medicine and Genetics
Dr. Ford is a medical oncologist and geneticist at Stanford, devoted to studying the genetic basis of breast and GI cancer development, treatment and prevention. Dr. Ford graduated in 1984 Magna Cum Laude (Biology) from Yale University where he later received his M.D. degree from the School of Medicine in 1989. He was a internal medicine resident (1989-91), Clinical Fellow in Medical Oncology (1991-94), Research Fellow of Biological Sciences (1993-97) at Stanford, and joined the faculty in 1998. He is currently Associate Professor of Medicine (Oncology) and Genetics, and Director of the Stanford Cancer Genetics Clinic, at the Stanford University Medical Center. Dr. Ford’s research goals are to understand the role of genetic changes in cancer genes in the risk and development of common cancers. He studies the role of the p53 and BRCA1 tumor suppressor genes in DNA repair, and uses techniques for high-throughput genomic analyses of cancer to identify molecular signatures for targeted therapies. Recently, his team has identified a novel class of drugs that target DNA repair defective breast cancers, and have opened clinical trials at Stanford and nationally using these “PARP inhibitors” for the treatment of women with “triple-negative” breast cancer. Dr. Ford’s clinical interests include the diagnosis and treatment of patients with a hereditary pre-disposition to cancer. He runs the Stanford Cancer Genetics Clinic, that sees patients for genetic counseling and testing of hereditary cancer syndromes, and enters patients on clinical research protocols for prevention and early diagnosis of cancer in high-risk individuals.
VP Precision Oncology
Principal Scientist, Statistical Genetics
Julie Granka is a biologist and a statistician with expertise in genetics and evolution who currently serves as the Director of Personalized Genomics at Ancestry.com. Dr. Granka has experience developing and applying advanced computational tools to genetic data to understand population history and evolution. During fieldwork in South Africa, she collected and analyzed DNA samples from an African hunter-gatherer population to uncover the genetic basis of human height and skin pigmentation. Dr. Granka has also analyzed numerous other African populations to identify regions of the human genome where positive natural selection has occurred in recent history. In addition, she has studied the genetics of other organisms, including M. tuberculosis, the organism that causes tuberculosis. Dr. Granka received a B.S. in Biometry and Statistics from Cornell University where she worked with Dr. Carlos Bustamante. Afterwards, she received an M.S. in Statistics and a Ph.D. in Biology with Dr. Marcus Feldman at Stanford University.
Deane F. and Kate Edelman Johnson Professor of Law
Henry T. "Hank" Greely is the Deane F. and Kate Edelman Johnson Professor of Law and Professor, by courtesy, of Genetics at Stanford University. He specializes in ethical, legal, and social issues arising from advances in the biosciences, particularly from genetics, neuroscience, and human stem cell research. He chairs the California Advisory Committee on Human Stem Cell Research and the steering committee of the Stanford University Center for Biomedical Ethics, and directs the Stanford Center for Law and the Biosciences and the Stanford Program in Neuroscience and Society. He serves as a member of the NAS Committee on Science, Technology, and Law; the NIGMS Advisory Council, the Institute of Medicine’s Neuroscience Forum, and the NIH Multi-Center Working Group on the BRAIN Initiative. Professor Greely graduated from Stanford in 1974 and from Yale Law School in 1977. He served as a law clerk for Judge John Minor Wisdom on the United States Court of Appeals for the Fifth Circuit and for Justice Potter Stewart of the United States Supreme Court. He began teaching at Stanford in 1985.
William Greenleaf is an Associate Professor in the Genetics Department at Stanford University School of Medicine, with a courtesy appointment in the Applied Physics Department. He is a member of Bio-X, the Biophysics Program, the Biomedical Informatics Program, and the Cancer Center. He received an A.B. in physics from Harvard University (summa cum laude) in 2002, and received a Gates Fellowship to study computer science for one year in Trinity College, Cambridge, UK (with distinction). After this experience abroad, he returned to Stanford to carry out his Ph.D. in Applied Physics in the laboratory of Steven Block, where he investigated, at the single molecule level, the chemo-mechanics of RNA polymerase and the folding of RNA transcripts. He conducted postdoctoral work in the laboratory of X. Sunney Xie in the Chemistry and Chemical Biology Department at Harvard University, where he was awarded a Damon Runyon Cancer Research Foundation Fellowship, and developed new fluorescence-based high-throughput sequencing methodologies. He moved to Stanford as an Assistant Professor in November 2011. Since beginning his lab, he has been named a Rita Allen Foundation Young Scholar, an Ellison Foundation Young Scholar in Aging (declined), a Baxter Foundation Scholar, and a Chan-Zuckerberg Investigator. His highly interdisciplinary research links molecular biology, computer science, bioengineering, and genomics a to understand how the physical state of the human genome controls gene regulation and biological state. Efforts in his lab are split between building new tools to leverage the power of high-throughput sequencing and cutting-edge microscopies, and bringing these new technologies to bear against basic biological questions of genomic and epigenomic variation. His long-term goal is to unlock an understanding of the physical “regulome” — i.e. the factors that control how the genetic information is read into biological instructions — profoundly impacting our understanding of how cells maintain, or fail to maintain, their state in health and disease.
Professor (by courtesy), Biology
Arthur Grossman has been a Staff Scientist at The Carnegie Institution for Science, Department of Plant Biology since 1982, and holds a courtesy appointment as Professor in the Department of Biology at Stanford University. He has performed research across fields ranging from plant biology, microbiology, marine biology, ecology, genomics, engineering and photosynthesis and initiated large scale algal genomics by leading the Chlamydomonas genome project (sequencing of the genome coupled to transcriptomics). During his tenure at Carnegie, he mentored more than fifteen PhD students and approximately 40 post-doctoral fellows (many of whom have become very successful independent scientists at both major universities and in industry). In 2002 he received the Darbaker Prize (Botanical Society of America) for work on microalgae and in 2009 received the Gilbert Morgan Smith Medal (National Academy of Sciences) for the quality of his publications on marine and freshwater algae. In 2015 he was Vice Chair of the Gordon Research Conference on Photosynthesis and in 2017 was Chair of that same conference (Photosynthetic plasticity: From the environment to synthetic systems). He also gave the Arnon endowed lecture on photosynthesis in Berkeley in March of 2017, has given numerous plenary lectures and received a number of fellowships throughout his career, including the Visiting Scientist Fellowship - Department of Life and Environmental Sciences (DiSVA), Università Politecnica delle Marche (UNIVPM) (Italy, 2014), the Lady Davis Fellowship (Israel, 2011) and most recently the Chaire Edmond de Rothschild (to work IBPC in Paris in 2017-2018). He has been Co-Editor in Chief of Journal of Phycology and has served on the editorial boards of many well-respected biological journals including the Annual Review of Genetics, Plant Physiology, Eukaryotic Cell, Journal of Biological Chemistry, Molecular Plant, and Current Genetics. He has also reviewed innumerable papers and grants, served on many scientific panels that has evaluated various programs for granting agencies [NSF, CNRS, Marden program (New Zealand)] and private companies. He has also served on scientific advisory boards for both nonprofit and for profit companies including Phoenix Bioinformatics, Excelixis, Martex, Solazyme/TerraVia, Checkerspot and Phycoil.
Senior Director, Medical Affairs
Puma Biotechnology, Inc.
Senior Scientist
DKFZ German Cancer Research Center
Natalie is a Post-Doctoral Scientist in the laboratory of Professor Michael Snyder at Stanford University. Her duties include applying approaches comprising genome sequencing, transcriptomics, and proteomics to the analysis of human disease, to help understand the molecular basis of disease and aid the development of diagnostics and therapeutics.
Dennis Farrey Family Professor of Genetics
Mark A. Kay, MD, PhD, is the Director of the Program in Human Gene Therapy, and Professor in the Department of Pediatrics and Genetics at Stanford University School of Medicine. Dr. Kay is one of the founders of the American Society of Gene Therapy and served as its President in 2005-2006. Dr. Kay received the E. Mead Johnson Award for Research in Pediatrics in 2000 and was elected to the American Society for Clinical Investigation in 1997. He has organized many national and international conferences, including the first Gordon Conference related to gene therapy.
Kay is respected worldwide for his work in gene therapy for hemophilia and viral hepatitis. He is an Associate Editor of Human Gene Therapy and Molecular Therapy, and a member of the editorial boards of other peer-reviewed publications.
Here at Stanford University, Dr. Kay is involved in many committees, including the Administrative Panel on Biosafety Committee, and Chair of the Berry Foundation Committee. Along with his work in Gene Therapy Dr. Kay is an avid photographer and enjoys spending time outdoors photographing wildlife.
Professor, Developmental Biology (Emeritus)
Dr. Kim's lab's research focuses are in C. elegans aging, human aging, cell lineage analyzer, and ModENCODE.
Students, fellows, and faculty in the Department of Developmental Biology are working at the forefront of basic science research to understand the molecular mechanisms that generate and maintain diverse cell types in many different contexts, including the embryo, various adult organs, and the evolution of different species. Research groups use a wide array of cutting-edge approaches including genetics, genomics, computation, biochemistry, and advanced imaging, in organisms ranging from microbes to humans. This work has connections to many areas of human health and disease, including stem cell biology, aging, cancer, diabetes, arthritis, infectious disease, autoimmune disease, neurological disorders, and novel strategies for stimulating repair or regeneration of body tissues.
Regenerative Patch Technologies
President of Research and Development, Asterias
Professor, Pathology and Genetics
Since participating in the initial identification of the protein product of the v-Myb oncogene as a postdoctoral fellow, Dr. Lipsick has dedicated his research career to understanding the function of the highly conserved Myb oncogene family. The laboratory has initially focused on the retroviral v-Myb oncogene and its cellular homologue, c-Myb. More recently, they have focused on the fruit fly Drosophila melanogaster as a model organism for understanding the human Myb oncogene family. They created the first null mutants of the sole Drosophila Myb gene, and showed that the absence of Myb resulted in mitotic abnormalities including chromosome condensation defects, aneuploidy, polyploidy, and aberrant spindle formation. In collaboration with the laboratory of Michael Botchan (UC Berkeley), they also showed that Myb was required for the site-specific initiation of DNA replication that occurs during chorion gene amplification in adult ovarian follicle cells. They themselves then showed that the absence of Myb causes a failure in the normal progression of chromosome condensation from heterchromatin to euchromatin. Most recently, they have found that Myb acts in opposition to repressive E2F and RB proteins to epigenetically regulate the expression of key components of the spindle assembly checkpoint and spindle pole regulatory pathways.
Adjunct Professor, Genetics
Kelly Ormond is a genetic counselor (US ABGC certified) and ELSI researcher. She received her MS in Genetic Counseling from Northwestern University (1994) and a post-?graduate certificate in Clinical Medical Ethics from the MacLean Center at the University of Chicago (2001). She joined the Health Ethics and Policy Lab as a Senior Scientist in February 2021, and is an Adjunct Professor in the Department of Genetics at Stanford School of Medicine, Stanford University, California, USA
Sutardja Chuk Professor
Dr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
Vice President of Program Management
Jose loves talking about science, especially to non-scientists. He has been involved in science outreach and education since he first learned of the simplicity and beauty of the structure of DNA. Naturally, Jose went on to graduate school at Stanford where he received a M.A. in Education and a Ph.D. in Developmental Biology. His doctoral work focused on understanding how epigenetic regulators control the biology of adult stem cells. For example, when some of these regulators misbehave, stem cells are lost to the detriment of the tissue they normally maintain. Why? How? Well, Jose still doesn’t know, but he hopes his work helped add one more piece to the never-ending puzzle of scientific research. After finishing his Ph.D., Jose moved to St. Louis, MO and joined Monsanto as part of a rotational leadership program, where he’s been doing a number of fun things both close and far from his science background. His year-long rotations have spanned biotechnology regulation and policy, global technology strategy, and development of molecular detection technologies. All of these rotations have complemented each other and contributed to his passion for sustainably and safely increasing food productivity and agricultural efficiency. Jose’s favorite activity is backpacking and talking about how light his backpack is over an open fire under the Milky Way-splattered sky of the Sierra Nevada. When he’s not outdoors, which is more frequent than he’d like, Jose enjoys good beer (peanut butter chocolate milk stout is real and delicious), good music (Tool), and thoughtful discussions involving science, education and politics.
Bing Professor of Population Studies
Jonathan Pritchard is a Professor of Genetics and Biology at Stanford University. He received his BSc in Biology and Mathematics from Penn State University in 1994, and his PhD in Biology at Stanford in 1998. After that he moved to a postdoc in the Department of Statistics at Oxford University and then to his first faculty job at the University of Chicago in 2001. He has been an Investigator of the Howard Hughes Medical Institute since 2008.
Associate Professor
George D. Smith Professor
Maria Grazia Roncarolo, MD is the co-director of the Institute for Stem Cell Biology and Regenerative Medicine, the George D. Smith Professor in Stem Cell and Regenerative Medicine, Professor of Pediatrics and of Medicine (blood and marrow transplantation), chief of the Division of Pediatric Stem Cell Transplantation and Regenerative Medicine, and co-director of the Bass Center for Childhood Cancer and Blood Diseases.
Dr. Roncarolo leads efforts to translate scientific discoveries in genetic diseases and regenerative medicine into novel patient therapies, including treatments based on stem cells and gene therapy. A pediatric immunologist by training, she earned her medical degree at the University of Turin, Italy. She spent her early career in Lyon, France, where she focused on severe inherited metabolic and immune diseases, including severe combined immunodeficiency (SCID), better known as the "bubble boy disease." Dr. Roncarolo was a key member of the team that carried out the first stem cell transplants given before birth to treat these genetic diseases.
While studying inherited immune diseases, Dr. Roncarolo discovered a new class of T cells. These cells, called T regulatory type 1 cells, help maintain immune system homeostasis by preventing autoimmune diseases and assisting the immune system in tolerating transplanted cells and organs. Recently, Dr. Roncarolo completed the first clinical trial using T regulatory type 1 cells to prevent severe graft-versus-host disease in leukemia patients receiving blood-forming stem-cell transplants from donors who were not genetic matches.
Dr. Roncarolo worked for several years at DNAX Research Institute for Molecular and Cellular Biology in Palo Alto, where she contributed to the discovery of novel cytokines, cell-signaling molecules that are part of the immune response. She studied the role of cytokines in inducing immunological tolerance and in promoting stem cell growth and differentiation.
Dr. Roncarolo developed new gene-therapy approaches, which she pursued as director of the Telethon Institute for Cell and Gene Therapy at the San Raffaele Scientific Institute in Milan. She was the principal investigator leading the successful gene therapy trial for SCID patients who lack an enzyme critical to DNA synthesis, which is a severe life-threatening disorder. That trial is now considered the gold standard for gene therapy in inherited immune diseases. Under her direction, the San Raffaele Scientific Institute has been seminal in showing the efficacy of gene therapy for otherwise untreatable inherited metabolic diseases and primary immunodeficiencies.
Dr. Roncarolo's goal at Stanford is to build the teams and infrastructure to move stem cell and gene therapy to the clinic quickly and to translate basic science discoveries into patient treatments. In addition, her laboratory continues to work on T regulatory cell-based treatments to induce immunological tolerance after transplantation of donor tissue stem cells. In Nature Medicine, Dr. Roncarolo recently published her discovery of new biomarkers for T regulatory type 1 cells, which will be used to purify the cells and to track them in patients. She also is investigating genetic chronic inflammatory and autoimmune diseases that occur due to impairment in T regulatory cell functions.
Elaine and John Chambers Professor
Dr. Sage studied biology at the École Normale Supérieure in Paris and did his PhD at the University of Nice and post-doctoral training at MIT. He is currently the Elaine and John Chambers Professor in Pediatric Cancer and a Professor of Genetics at Stanford University where he serves as the co-Director of the Cancer Biology PhD program. For his work on cancer genetics, he has been awarded a Damon Runyon Cancer Research Foundation Scholar Award, a Leukemia and Lymphoma Society Scholar Award, and an R35 Outstanding Investigator Award from the National Cancer Institute. Dr. Sage’s work has focused on the RB tumor suppressor pathway and how inactivation of RB promotes tumorigenesis in children and adult patients. In the past few years, the Sage lab has developed pre-clinical models for small cell lung cancer, an RB-mutant cancer, and has used these models to investigate signaling pathways driving the growth of this cancer type and to identify novel therapeutic targets in this recalcitrant cancer.
Associate Professor, Genetics Member, Stanford Cancer Institute
Army Breast Cancer Research Fellowship, Department of Defence (1997-1998) Cold Spring Harbor Fellowship, Cold Spring Harbor Laboratory (1996-1997) Prize Studentship, The Wellcome Trust (1991-1994) John Buckley Entrance Scholarship for Science, Manchester University (1988-1991)
B.Sc., Manchester University, Genetics (1991) Ph.D., Manchester University, Molecular Biology (1994)
Stanford W. Ascherman Professor of Genetics
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University.
He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has launched many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species.
He has also combined different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of several biotechnology companies, including Protometrix (now part of Life Tehcnologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies
Senior Science Writer
Barry received his B.S. from CSU, Chico in Biochemistry. He then went on to graduate school at the University of Oregon where he earned his Ph.D. in biochemistry with Dr. Diane Hawley. During his six years, Barry worked on many aspects of basal RNA polymerase II transcription but Barry’s main contribution to the field was showing that the TATA-binding protein (TBP) recognized its AT-rich sequence entirely through the minor groove. This was deemed impossible at the time. Barry then went on to do a postdoc with Dr. Keith Yamamoto at UCSF where he worked on glucocorticoid receptor mutants. After that Barry entered the world of biotechnology where he was employed at three different companies designing small molecules that could specifically alter gene expression. He then stepped off the standard science track and took a job with Stanford University’s Department of Genetics running an outreach program called Stanford at The Tech. Over the next ten or so years Barry helped design and update a museum exhibition (Genetics: Technology With a Twist), a website (Understanding Genetics), have given over 100 graduate students and postdoctoral fellows the opportunity to improve their communication skills, and have written hundreds of blogs both for the Understanding Genetics website and for KQED QUEST, a local PBS television show.
Dieter Schwarz Foundation Endowed Professor
Lars Steinmetz studied molecular biophysics and biochemistry at Yale University and conducted his Ph.D. research on genome-wide approaches to study gene function and natural phenotypic diversity at Stanford University. After a brief period of postdoctoral research at the Stanford Genome Technology Center, where he worked on functional genomic technology development, he moved to Europe in 2003. At the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, he started his own group, focused on applying functional genomic approaches and high-throughput methods to study complex traits, transcription and the mitochondrial organelle at a systems level. In parallel, he maintained a focused group at the Stanford Genome Technology Center working on technology development. Since 2009, Lars acted as Joint Head of the department of Genome Biology at EMBL.
In October 2013 Lars became Professor of Genetics at Stanford University and Co-Director of the Stanford Genome Technology Center. His lab develops and applies cutting-edge technologies to investigate the function and mechanism of transcription, the genetic basis of complex phenotypes and the genetic and molecular systems underpinning disease. Their ultimate goal is to enable the development of personalized, preventative medicine.
In parallel to his research activities at Stanford, Lars continues to lead his lab at EMBL and acts as Associate Head of Genome Biology and Senior Scientist at EMBL. His Stanford and EMBL labs collaborate very closely.
In addition to his academic endeavours, Lars is a consultant and board member of several companies, advising in the areas of genetics and personalized medicine.
Senior Product Scientist I
Ruth Tennen picked up her first pipette as a summer high-school student in a lab at the University of Connecticut Health Center. She received her bachelor’s degree in molecular biology from Princeton University and her Ph.D. in cancer biology from Stanford University. Her graduate work examined the intersection between epigenetics and disease: how human cells squeeze two meters of DNA into their nuclei while keeping that DNA accessible and dynamic, and how DNA packaging goes awry during cancer and aging. As a graduate student, Ruth shared her love of science by teaching hands-on classes to students at local schools, hospitals, and museums and by blogging on the San Jose Tech Museum’s website.
After completing her Ph.D., Ruth moved to Washington, DC to serve as an AAAS Science & Technology Policy Fellow. Working in the Bureau of African Affairs at the U.S. Department of State, she collaborated with colleagues in DC and at U.S. Embassies abroad to promote scientific capacity building, science education, and entrepreneurship in sub-Saharan Africa. She managed the Apps4Africa program, which challenges young African innovators to develop mobile apps that tackle problems in their communities. She also traveled to South Africa and Ghana, where she delivered lectures and workshops designed to spark the scientific excitement of young learners.
Ruth is currently a Product Scientist at 23andMe. In her free time, Ruth enjoys running, reading, quoting Seinfeld, and cheering for the UConn Huskies.
Bayer Pharmaceuticals
Postdoc, Genetics
DFG Fellowship (2013)
Research Interest: Gene Therapy, (Stem) Cell Therapy, Genome Engineering, CRISPR/Cas9 gene editing
Associate Professor of Genetics and of Pathology
Monte Winslow is an Associate Professor of Genetics and Pathology at Stanford University.
Commercial Planning Manager
Adaptive Biotechnologies Corp.
Stacey received her B.A. in Biology from Wellesley College and her Ph.D. in Cancer Biology from Stanford University. Her dissertation focused on uncovering new mechanisms for cell cycle control in mouse embryonic stem cells and neural progenitors. She went on to complete a post-doctoral fellowship in genome engineering, where she worked to develop nuclease technology for editing disease-causing mutations in human stem cells. In her spare time, Stacey volunteers at the San Jose Tech Museum, likes to camp and hike throughout Northern California, and is an avid photographer.
Simon H. Stertzer, MD, Professor
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Professor in the Department of Medicine (Cardiology) and Department of Radiology (Molecular Imaging Program) at the Stanford University School of Medicine. Dr. Wu received his medical degree from Yale. He completed his medicine internship, residency and cardiology fellowship training at UCLA followed by a PhD (Molecular & Medical Pharmacology) at UCLA. Dr. Wu has received several awards, including the Burroughs Wellcome Foundation Career Award in Medical Sciences, Baxter Foundation Faculty Scholar Award, AHA Innovative Research Award, AHA Established Investigator Award, NIH Director’s New Innovator Award, NIH Roadmap Transformative Award, and Presidential Early Career Award for Scientists and Engineers given out by President Obama. He is on the editorial board of Journal Clinical Investigation, Circulation Research, Circulation Cardiovascular Imaging, JACC Imaging, Human Gene Therapy, Molecular Therapy, Stem Cell Research, and Journal of Nuclear Cardiology. He is a Council Member for the American Society for Clinical Investigation and a Scientific Advisory Board Member for the Keystone Symposia. His clinical activities involve adult congenital heart disease and cardiovascular imaging. His lab research focuses on stem cells, drug discovery, and molecular imaging.
You may also like.
Stanford School of Medicine, Stanford Center for Health Education
SOM-XCHE0025
Human genetics.
The Vanderbilt Human Genetics PhD program (HGEN) has served as a model of successful interdisciplinary biomedical research to graduate students since its inception. Genetics is the study of variation in and transmission of hereditary material from generation to generation and how this information is translated into biological function. Genetics utilizes multiple techniques to understand the variation, transmission and function of hereditary material from the molecular level to the population level. Because of the pervasive impact of genetic variation on biological function, genetics has become a unifying theme for much research in the biological and biomedical sciences and can serve as a focus for the study of virtually all biological processes and systems. Genetics plays an ever increasing role in elucidation of the cellular and molecular mechanisms of human disease and birth defects, as well as in their prevention, diagnosis and therapy. In addition to the use of genetics to study biomedical questions posed by other fields, genetics encompasses an important set of questions as to how the information content of a set of relatively simple molecules can be translated into complex organisms, how variation at the molecular level can cause differences among individuals in terms of normal variation and disease processes, and how this variation within and among populations can be used to explain differences in disease prevalence.
RESEARCH AREAS IN HUMAN GENETICS |
Researchers at the Vanderbilt Center for Human Genetics Research are studying human traits using multiple approaches. Examples include: |
Mouse, Zebra Fish, Flies, Cell Culture |
Breast, Colon, and Prostate Cancer, Alzheimer’s Disease, Autism, Multiple Sclerosis, Cardiac Arrhythmia, Cardiovascular Disease, Hypertension, Thrombosis, Diabetes, Obesity, AIDS, Malaria, Tuberculosis Susceptibility, AMD, Glaucoma, Mitochondrial Disease, Pre-term Birth |
Health disparities among European, African American, Hispanic & Asian populations |
Gene-gene interactions, gene-environment interactions, systems genomics, high throughput sequencing |
The graduate program in Human Genetics is the home within the Division of Biological Sciences for the study of basic principles of genetics and genomics as applied to human phenotypes. We provide broad training in experimental and computational genetics and genomics, statistical and population genetics, bioinformatics, and clinical genetics. A common theme throughout our research is the application of basic genetic principles and strategies to the study of disease mechanism, disease susceptibility, and the genetic architecture of complex traits. Within this framework, the goals of our program are to:
Students are encouraged to take advantage of interactive and collaborative relationships at departmental, divisional, and university-wide levels. Our faculty bridge between basic and clinical research and train students for careers in academia, industry, and medicine. Recent graduates have obtained post-doctoral positions at Cornell University, Harvard University, the National Institutes of Health, Sanger Centre, UC Berkeley, UCSF, and UCLA. Other graduates hold faculty positions, practice medicine, or work in leadership positions in the biomedical industry.
First year of study.
Regardless of previous academic or laboratory experience, the first year of PhD study is spent taking classes, exploring research opportunities, and performing laboratory rotations. Students join a lab at the conclusion of the first year of study, after successfully passing a preliminary examination.
Before joining a lab, students attend bi-weekly seminars (informally referred to as “Allstars”) where divisional faculty present their research programs. They also undertake two or three laboratory rotations to acquaint them with the full spectrum of research and trainers available to them.
Students spend the second year developing a research project and preparing a written proposal of dissertation research. This proposal is defended before a qualifying examination committee at the end of the academic year. Students satisfy any remaining course requirements and complete at least one of the two required Teaching Assistantships during this year.
After the qualifying exam, the student performs full-time thesis research while continuing to participate in departmental events such as seminars, journal clubs, etc. Students are welcome to audit courses in which they have an interest. Finally, in the final year of the program the student writes a dissertation describing his or her research, presents the work in a public seminar and defends it before his/her faculty examining committee. Please view the Human Genetics Handbook for a full description of the academic program and the courses available to our students.
Students are encouraged to interact with the diagnostic genetics labs and to attend the clinical case conferences.
We admit highly-qualified, academically-curious scientists to our program. Many applicants enter the PhD program directly from undergraduate study, while others come to the program after working in research laboratories or industry. Successful PhD program applicants present excellent academic credentials in biology and statistics and strong letters of recommendation. We seek applicants with superior writing skills and substantial research experience. We strongly encourage applications from underrepresented minorities in the biological sciences.
Submit your completed application by December 1 . Submit a single application to UChicago Biosciences. Click here for additional information .
UChicago Biosciences offers academically qualified applicants full and equitable support. Such assistance is guaranteed through the student’s first five years of study, conditional on satisfactory degree progress, and is extended to completion of degree in all but the most unusual of circumstances. Financial support includes tuition and fees, and provides a stipend. The graduate stipend is maintained at a level affording a reasonable local standard of living, is competitive with awards offered at comparable institutions, and is periodically adjusted in response to cost-of-living increases. Click here for additional information.
HOW TO APPLY TO THE UCHICAGO BIOSCIENCES PROGRAM
Department news.
August 22, 2024
Cynthia M. Powell, MD, MS, FAAP, Professor of Pediatrics, in the Division of Genetics and Metabolism, and Genetics received the Outstanding Academic Service Award in recognition of her groundbreaking work in genetics and newborn screening as well as her trusted partnership with pediatricians across North Carolina.
August 21, 2024
Melissa Haendel, PhD, FACMI (Distinguished Professor, Genetics) is the contact PI for the recently transferred RM1 grant from NHGRI titled “A phenomics-first resource for interpretation of variants”.
Sabrina Toro, PhD (Assistant Professor, Genetics) has been awarded an R24 from NIEHS for her project titled “Advancing a community-led zebrafish toxicology phenotype atlas”.
August 19, 2024
Courtney Thaxton, PhD was promoted to Associate Professor, effective July 1, 2024.
More…
We advance fundamental, translational, and clinical research in genetics and genomics through innovation, education, and collaboration.
Our graduate programs train students to be creative, sophisticated research scientists prepared to pursue careers focused in genetics and genomics working in academic science, government, or commercial positions. Students conduct their dissertation research using diverse experimental approaches – from classical genetics to the most modern molecular methods – to address a broad range of contemporary problems in biomedical science.
The Department also includes a clinical arm focused on medical genetics, which covers the broad spectrum of clinical genetic research from disease prevention to diagnosis and treatment. This specialty includes evaluation, mutation discovery, counseling and risk assessment through analysis and genetic testing. Locating the clinical group alongside basic scientists facilitates integration of cutting edge genetic research with patient care.
For more information, including our mission, goals, board members and training videos, please visit the new website here !
Kristy Lee, MS, CGC
The Department of Genetics is proud to highlight Professor, Ms. Kristy Lee, for her excellence in clinical service, research, and service. Ms. Lee’s scientific expertise, clinical experience, teaching excellence, and service to the community exemplifies her long-standing commitment to the utilization of genetics in healthcare.
Read Full Story.
Genetics news.
Monday – bcb colloquium – qingyun liu & adam palmer.
Monday 4:00 pm
Tuesday 9:00 am
Wednesday 12:00 pm
Thursday 10:00 am
Monday 12:00 am
Wednesday – department of genetics colloquium: kate foreman, research at unc with all of us data workshop series – getting started.
Thursday 11:30 am
Boston University
For contact information, please visit the Graduate Program in Genetics & Genomics website .
The Graduate Program in Genetics & Genomics aims to teach our students not only how to apply the approaches of hypothesis-testing genetics and hypothesis-generating genomics to biomedical research, but also how to function as ethical members of the scientific community who can clearly communicate ideas, critically evaluate biomedical research, mentor others in scientific scholarship, and promote equity in their professional activities.
The doctoral programs in Graduate Medical Sciences at BU Chobanian & Avedisian School of Medicine are designed to train scholars to be leaders in their respective fields of biomedical research. Trainees become fluent in their areas of specialization, as well as develop competencies that provide the foundation for lifelong learning and practice in their chosen field. Trainees will demonstrate and apply the professional and scientific skills necessary to benefit society. The program objectives are delineated below.
By graduation, a Genetics & Genomics PhD student will:
Toward this end, we have designed a complementary set of degree requirements to meet these goals consisting of traditional coursework, journal clubs, seminar series, and a research proposal–based qualifying examination for PhD students. The coursework will be completed during the first two years of study. Students matriculate in September of their first year as Program in Biomedical Sciences (PiBS) PhD students, and they choose their degree-granting program at the end of their first year. The academic program requirements below reflect the combined program of study.
Please see the general description of the MD/PhD program for combined degree requirements.
For MD/PhD Candidates:
For PhD/MS Candidates:
See Courses for detailed descriptions.
Our PhD candidates participate in a minimum of three laboratory rotations to ensure exposure to a variety of scientific approaches. These rotations will last 7–10 weeks each, with one during the fall term and two during the spring term. The rotations are organized during the first year of study while the students are PiBS students and before they officially join the Graduate Program in Genetics & Genomics. PiBS students begin their first year of studies in the fall term and join their degree-granting program at the end of the spring of their first year. Due to time constraints, MD/PhD students will have the option of joining a dissertation laboratory after two rotations. The academic and research components of the program together typically take 5–6 years of full-time academic study to complete for PhD students, and 4–5 years for dual degree MD/PhD students.
Upon successful completion of the core courses, PhD students serve as teaching assistants (TAs) for one of the program’s courses. The TAs will lead discussion and review sections as well as support exam and homework grading. The TA assignments will be made according to academic performance in the courses in question and with student input. Acting as a TA for one course will satisfy the teaching requirement for the PhD degree, but further teaching opportunities will be available for students who are interested in developing these skills.
Successful completion of the coursework and rotations during the first two years of graduate study will prepare the PhD students to advance to PhD candidacy through the qualifying process. This process depends on the following sequence of events:
Upon advancing to PhD candidacy, graduate students will focus on their dissertation research. This research will be conducted under the supervision of their chosen graduate advisor. The student will be responsible for conducting a rigorous, in-depth program of investigation into an area of research that is within the scope of their graduate advisor’s expertise and interests. The student’s progress will be assessed continuously by the graduate advisor and annually by a Dissertation Advisory Committee. This committee will be composed of the student’s advisor and at least four other faculty members with a minimum of two faculty members from the Graduate Program in Genetics & Genomics and one division faculty member from an outside program. The Dissertation Advisory Committee will serve to provide outside perspectives on the research program.
While the student is conducting dissertation research, they are expected to actively participate in program seminar series, lab meetings, and other research activities of their dissertation lab. It should be noted that the Boston University Genome Science Institute hosts seminars, including talks from prominent scientists from other institutions as well as talks from scientists with overlapping interests to the program here at BU. Students also have the opportunity to interact more privately with visiting seminar speakers through organized student lunch forums. Students and postdocs also participate in a Research in Progress series of seminars that gives trainees an opportunity to share their research and to learn more about the science going on in the Genetics & Genomics community of Boston University. Furthermore, students will be expected to study “The Responsible Conduct of Research” that is currently available to the Chobanian & Avedisian School of Medicine through ENG EK 800.
It is the job of the Dissertation Advisory Committee to facilitate expeditious progress toward the PhD, with most students graduating in 5–6 years total. Once the research has developed into several chapters of publication-quality work, the advisory committee will ask the student to begin compiling their written dissertation, and a date for the Graduate Medical Sciences public seminar and formal dissertation defense will be scheduled. The public seminar will be delivered to a general audience of Graduate Medical Sciences faculty, students, and researchers. Later that day, the public seminar will be followed by a formal dissertation defense, which will occur behind closed doors in the presence of the Dissertation Advisory Committee. This committee will evaluate the student’s dissertation defense and written dissertation for satisfactory completion of the degree requirements.
Note that this information may change at any time. Read the full terms of use .
Boston University is accredited by the New England Commission of Higher Education (NECHE).
As part of our series on How to Fully Fund Your PhD , here is a list of universities that offer fully funded PhD programs in Genetics. A PhD in Genetics opens up many exciting career opportunities in various sectors, including academia, research institutions, industry, and government.
“Full funding” is a financial aid package for full-time students that includes full tuition remission and an annual stipend or salary for three to six years of the student’s doctoral studies. Funding is typically offered in exchange for graduate teaching and research work complementary to your studies. Not all universities provide full funding for a PhD in Genetics, which is why we recommend researching the financial aid offers at all the potential PhD programs in your academic field, including smaller and lesser-known schools both in the U.S. and abroad.
You can also find several external fellowships in the ProFellow database for graduate and doctoral study, as well as dissertation research, fieldwork, language study, and summer work experience.
Would you like to receive the full list of more than 1000+ fully funded programs in 60 disciplines? Download the FREE Directory of Fully Funded Graduate Programs and Full Funding Awards !
The University of Wisconsin-Madison offers a fully funded PhD in Genetics. The Genetics Training Program provides exceptional opportunities to students. The mission is to train students in cutting-edge genetic and genomic research while providing professional development opportunities for successful career trajectories. Students accepted into the PhD degree program initially receive financial aid from either an NIH training grant or graduate school fellowships. In later years, support may be derived from a research assistantship. Genetics students also receive funding from competitive fellowships.
Johns Hopkins University, based in Baltimore, Maryland, offers a fully funded PhD in Human Genetics and Genomics. The Johns Hopkins Human Genetics Training Program provides training in all aspects of human genetics and genomics relevant to human biology, health, and disease. The program is supported by a training grant from the National Institute of General Medical Sciences. These fellowships, which are restricted to United States citizens and permanent United States residents, cover tuition, health care insurance, and a stipend during year one. Once a student has joined a thesis lab, all financial responsibilities belong to the mentor.
The University of British Columbia, based in Canada, offers a fully funded PhD in Medical Genetics. Faculty members in the Department of Medical Genetics are at the forefront of their fields using cutting-edge genetic, epigenetic, genomic, and bioinformatic methodologies to gain insight into diseases such as cancer, diabetes, obesity, neurodegenerative and neurological disorders, and other genetic diseases. The recommended minimum yearly stipend for full-time Medical Genetics thesis-based students (Canadian and international) is $28,000 (PhD). The duration of the annual stipend is normally four years for a PhD student. New and current doctoral students at UBC receive the President’s Academic Excellence Initiative PhD Award (PAEI) tuition award.
Indiana University, based in Indianapolis, IN, offers a fully funded PhD in Medical and Molecular Genetics. The Department provides a wide range of research opportunities in the rapidly changing field of human genetics. Students have the freedom to explore research areas through three rotations in laboratories across programs and choose entry into any of the ten PhD programs at the conclusion of the first academic year. Students receive competitive stipends, tuition scholarships, and health insurance. PhD students with eligibility to work in the U.S. receive a competitive annual stipend without a Teaching Assistant requirement as well as tuition scholarships and health and dental insurance.
The University of Iowa, based in Iowa City, IA, offers a fully funded PhD in Genetics. The interdisciplinary PhD program trains students on the frontiers of Genetics research and develops leaders that meet the upcoming challenges in the field of Genetics. Students in the Interdisciplinary Graduate Program in Genetics are eligible for financial support through a combination of training grants, scholarships, fellowships, research assistantships, teaching assistantships, University support, and revenue from the Carver Trust. Genetics students receive a guaranteed stipend ($33,000 in 2023 – 2024), full tuition, mandatory fees, and health insurance allowance.
Stanford University, based in Stanford, California, offers a fully funded PhD in Genetics. The Genetics PhD program provides opportunities for graduate study in all major areas of modern genetics, including identification and analysis of human disease genes, molecular evolution, gene therapy, statistical genetics, application of model organisms to problems in biology and medicine, and computational and experimental approaches to genome biology. Students receive a competitive stipend ($48, 216 for the 2022-23 Academic Year), tuition, health insurance, and a dental care stipend for a full four years.
McGill University, based in Canada, offers a fully funded PhD in Human Genetics. The Department of Human Genetics provides a unified curriculum of study in genetics. Areas of specialization include biochemical genetics, genetics of development, animal models of human diseases, cancer genetics, molecular pathology, gene therapy, genetic dissection of complex traits, genetics of infectious and inflammatory diseases, non-mendelian genetics, bioinformatics, behavioral genetics, neurogenetics, bioethics, and genomics. Funding amounts to cover tuition & stipend must be secured and guaranteed for the entire duration of a student’s degree program. This funding may be secured through research grants, scholarships, and/or cultural and government agencies. The department does not accept self-funded students.
Wayne State University, based in Detroit, Michigan, offers a fully funded PhD in Molecular Genetics and Genomics. This is a research-intensive graduate program that prepares students for careers in academia or industry. Molecular Genetics and Genomics graduate students receive broad training in genetics, molecular and cellular biology, genomics, functional genomics, systems biology, bioinformatics, and computational and statistical methods. A major component of their training is conducting dissertation research in one of the focus areas of the Center faculty. PhD students are funded by a Graduate Research Assistantship (GRA) that includes a competitive stipend, paid tuition, and subsidized medical insurance.
Interested in finding funding for graduate school? Sign up to discover and bookmark more than 2,700 professional and academic fellowships, including 1,000+ fully funded Master’s and PhD programs, in the free ProFellow database .
© 2024 ProFellow, LLC, all rights reserved.
Biomedical Science Fellowships , Fully Funded PhD Programs , PhD in Genetics
The role of a kind-hearted mentor in maximizing your fellowship opport..., find and win paid, competitive fellowships.
Be alerted about new fellowship calls for applications, get insider application tips, and learn about fully funded PhD and graduate programs
ProFellow is the go-to source for information on professional and academic fellowships, created by fellows for aspiring fellows.
©2011-2024 ProFellow, LLC. All rights reserved.
You are using an outdated browser. Please upgrade your browser to improve your experience. Thanks!
Welcome to the Graduate Program in Genetics!
Our Commitment to Diversity, Equity, and Inclusion
Samantha Henry will present her dissertation research on 7/25
Shaobo Qin will present her dissertation research on 7/29
Courtney Tello earns an NIH/NIGMS F31 fellowship
Xiao Han receives an NIH/NCI F99/K00 fellowship
Qingting Hu and Joanne Saldanha receive Mow Shiah Lin scholarships
Welcome to the Genetics 2023 entering class!
Steven Lewis and Lucia Yang receive NIH/NCI fellowships
Welcome BBQ August 2023
End-of Year Lunch July 2023
Retreat/Recruitment Event March 2023
Welcome Lunch August 2022
Welcome Lunch August 2021
Welcome Picnic August 2019
Welcome Picnic August 2018
Retreat/Recruitment Event February 2018
Retreat/Recruitment Event February 2016
Campus Views
Harness the power of plants..
From crop-based biofuels to pest-resistant plants, discoveries of plant scientists make a profound impact on the world’s food production, natural resources and the environment.
This program prepares you to make your own contribution to this exciting field through the in-depth study of the production, protection, breeding and genetics of plants. Gain a sophisticated understanding of the interdisciplinary field, with specialized skills in areas like biotechnology, weed science, crop management, plant pathology and more.
Much of your experience will take place in the on-campus plant science farms, climate-controlled greenhouses and laboratories, where you will conduct independent research alongside leading faculty experts in the field.
This program could be a good fit if you:
With this degree, you could become a/an:
Available On-Campus
Nutritional Sciences, M.S.
Explore cutting-edge nutrition research to help improve human health.
Plant Pathology, M.S.
Explore interactions between plants and microbes. Learn to develop innovative solutions that keep plants safe from diseases.
Nutritional sciences, family and consumer sciences.
Learn scientific research methods to understand and solve problems of human development, family relations, personal and family finance, nutrition and community.
Develop your expertise and research skills in animal growth, nutrition, reproduction and other areas in animal agriculture.
Master the skills and techniques of teaching youth and adults about agriculture, leadership and life.
Lead original research in areas such as animal growth, nutrition or reproduction.
Develop valuable expertise in the sustainable use and management of soils.
Learn to work across disciplines to help communities solve today’s increasingly complex problems in water resources management.
Learn to research and develop new food products, improve the safety and quality of food products, and design safer and more efficient food processes.
Develop the skills to solve complex pest-control problems, tackle pressing pollination issues, and battle insect-borne diseases.
Applied economics.
Apply advanced statistical and mathematical analysis to solve complex issues involving agriculture, communities, natural resources and other applied topics.
Turn your passion for health and wellness into a career as a registered dietitian nutritionist.
Application requirements.
The Genetic Counselor Educators Association (GCEA) has established a waiver for the $100 fee associated with the NMS Match. Prospective students who demonstrate financial need and have a cumulative GPA of 3.0 or greater can apply for a match fee waiver. Deadline for application is October 4, 2024. Please click here for further instructions on applying for the waiver.
Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-8906
Doctoral degrees.
The University of Idaho awards the degree of Doctor of Philosophy in recognition of high achievement in scholarly and research activity. The degree of Doctor of Education is granted for high scholarly attainment and in recognition of the completion of academic preparation for professional practice. See the "Ph.D. and Ed.D. Procedures" tab for more details. The Doctor of Athletic Training is offered through the College of Education and the Department of Movement Sciences (see the "DAT Procedures" tab for more details).
The major professor and program offering a particular doctoral program indicate the general philosophy of the degree program, the objectives of courses and seminars, the research specialties available, and requirements unique to the department. Admission to the doctoral program is granted only to those who have a recognized potential for completing the degree.
Credit requirements.
For the Ph.D. and Ed.D., a minimum of 78 credits beyond the bachelor's degree is required.; At least 52 credits must be at the 500 level or above and at least 33 of the 78 credits must be in courses other than 600 (Doctoral Research and Dissertation). A maximum of 45 research credits in 600 (Doctoral Research and Dissertation) including 6 credits of 599 (Non-thesis Research) or 500 (Master's Research and Thesis) may be in the 45 research credits used toward the degree. For the D.A.T., a minimum of 66 credits is required and follows a prescribed set of courses set by the program.
Courses numbered below 300 may not be used to fulfill the requirements for a doctoral degree; courses numbered 300-399 may be used only in supporting areas and are not to be used to make up deficiencies. Individual programs may require additional course work. Applicants having a doctoral degree may obtain a second doctoral degree subject to the approval of the Graduate Council. The Graduate Council will establish the requirements for the second degree.
For the Ph.D. and Ed.D. degrees, a student must complete at least 39 of the 78 required credits at the University of Idaho (U of I) while matriculated in the College of Graduate Studies. Credits can be transferred to U of I with the consent of the student's major professor, the committee (if required by the program), the program's administrator, and the dean of the College of Graduate Studies. Credits can be transferred only if the institution from which the credits are being transferred has a graduate program in the course's discipline. All credits used toward graduate degrees must be from regionally accredited American institutions or from non-US institutions recognized by the appropriate authorities in their respective countries. Transfer credits are subject to all other College of Graduate Studies rules and regulations. Correspondence study courses may be applied to the degree only with the prior written approval of the College of Graduate Studies. Courses used toward an undergraduate degree, professional development courses, and courses on a professional development transcript are not available to be used toward a doctoral degree.
Of the credits submitted to satisfy the requirements for a Ph.D. or Ed.D. degree, a maximum of 30 may be more than eight years old when the degree is conferred, provided the student's committee and program administrator determine that the student has kept current in the subjects concerned. Graduation must occur no later than five years after the date on which the candidate passed their preliminary or general examination. These time limitations can be extended only on recommendation of the committee and approval by the Graduate Council.
Regulations are outlined in Section 4920 of the Faculty-Staff Handbook.
A period of professional practice is required for the Doctor of Education degree; the period involved is determined by the student's supervisory committee. While the Ed.D. is a College of Education degree, you should consult with the departments in the College of Education to learn of specific emphasis requirements.
Appointment of major professor and committee.
Refer to " Appointment of Major Professor and Committee for All Degree Seeking Graduate Students " in the preceding General Graduate Regulations section. In addition, a doctoral supervisory committee consists of at least four people: the major professor as chair and at least one additional UI faculty member from the program, the balance of the committee may be made up of faculty members from a minor or supporting area, and faculty members from a discipline outside the major. If the committee has a co-chair, the minimum number of committee members is five.
The qualifying examination is a program option and serves to assess the background of the student in both the major and supporting fields and to provide partially the basis for preparation of the student's study program. A particular program may or may not require a master's degree as a prerequisite for the qualifying evaluation. As soon as the program's qualifications are met, a supervisory committee is appointed.
Refer to " Preparation and Submission of Study Plan " in the preceding General Graduate Regulations section.
The preliminary examination should be scheduled only after the student has completed the majority of the courses on their study plan. The student is required to be registered during the semester the preliminary examination is taken. The student's committee certifies to the College of Graduate Studies the results of the preliminary examination and if passed, the student is advanced to candidacy. Graduation must occur no later than five years after the date on which the candidate passed their examination. If the preliminary examination is failed, it may be repeated only once; the repeat examination must be taken within a period of not less than three months or more than one year following the first attempt. If a student fails the preliminary examination a second time, or the program does not allow the student to repeat the examination after the first failure or the student does not retake the examination within one year, the student is automatically moved to unclassified enrollment status and is no longer in the degree program.
When the student approaches the end of their course work, has completed the professional experience requirement, and has outlined the dissertation subject in detail, the supervisory committee approves the holding of the general examination. The student is required to be registered during the semester the general examination is taken. The examination is both written and oral and is intended to assess progress toward degree objectives. The student's committee certifies to the College of Graduate Studies the results of the general examination and if passed, the student is advanced to candidacy. Graduation must occur no later than five years after the date on which the candidate passed their examination. If the general examination is failed, it may be repeated only once; the repeat examination must be taken within a period of not less than three months or more than one year following the first attempt. If a student fails the general examination a second time, or the program does not allow the student to repeat the examination after the first failure or the student does not retake the examination within one year, the student is automatically moved to unclassified status and is no longer in the degree program.
See the General Graduate Regulations section regarding application for advanced degree, registration requirements, final defense and dissertation requirements.
The culminating clinical project.
Students enrolled in the Doctor of Athletic Training (D.A.T.) will engage in research projects during the curricular phase of the program. These project(s) will lead to at least two publication ready manuscripts, and all students must meet professional authorship requirements (regardless of order). See the Department of Movement Sciences and Doctor of Athletic Training webpages for more information.
All D.A.T. project team committees will have at least four committee members: two members of the athletic training faculty (all with graduate faculty status), the student's attending clinician (who is the student's on-site mentor during the student's residency), and an expert in the student's chosen area of clinical research. The athletic training faculty members will always chair the CCP, provide research guidance, and serve as the experts in the development of advanced practice in Athletic Training. A situation may arise in which one or both of the members of the committee that are outside of the AT program faculty may have a degree less than that of which the student is seeking; however, the intent of the third and fourth D.A.T. committee membership is to provide outside validation of the student's progress toward advanced practice and clinical utility of action research studies.
These dissertation hours may be used in instances when the CCP has not been successfully completed and the curricular phase of program has been completed.
Send Page to Printer
Print this page.
Download Page (PDF)
The PDF will include all information unique to this page.
IMAGES
COMMENTS
Graduate Studies. The Genetics Ph.D. program provides opportunities for graduate study in all major areas of modern genetics, including identification and analysis of human disease genes, molecular evolution, gene therapy, statistical genetics, application of model organisms to problems in biology and medicine, and computational and experimental approaches to genome biology.
The overall objective of the Human Genetics program is to provide our students with a strong foundation in basic science by exposure to a rigorous graduate education in genetics, genomics, molecular biology, cell biology, biochemistry and biostatistics as well as a core of medically-related courses selected to provide knowledge of human biology in health and disease.
Columbia University. New York, NY. #10 in Genetics / Genomics / Bioinformatics (tie) Genetics and genomics courses examine heredity and DNA and, in bioinformatics, computer programs are used to ...
Stanford University School of Medicine. Stanford, CA ·. Stanford University ·. Graduate School. ·. 3 reviews. Doctoral Student: I begin in the Fall of 2023--Based on my interview, and pre-classes I have taken this program is amazing.
Program Description. The program provides a unified curriculum of study in genetics and genomics leading to the Ph.D. Areas of specialization include population and evolutionary genetics, microbial and viral genetics, human and mammalian genetics, developmental genetics, epigenomics, and plant genetics.
The Human Genetics PhD Program is within the Graduate Programs in Bioscience (GPB) The Genetics and Genomics Home Area, which is affiliated with the degree-granting Human Genetics PhD Program, is a member of the broader UCLA Graduate Programs in Bioscience (GPB). There are eleven different Home Areas in GPB, each consisting of an ...
The PhD program in Genetics is designed to provide the student with a broad background in general genetics and the opportunity to conduct original research in a specific area of genetics. The Genetics student is expected to acquire a broad understanding of genetics, spanning knowledge of at least three basic areas of genetics, which include ...
Program Overview. The Department of Human Genetics at the University of Michigan was founded by Dr. James V. Neel in 1956 and was the first human genetics department in the United States. The initial focus of the department was human heredity, and this view has grown in breadth and depth through the genomic and post-genomic eras.
Mark A. Kay, MD, PhD, is the Director of the Program in Human Gene Therapy, and Professor in the Department of Pediatrics and Genetics at Stanford University School of Medicine. Dr. Kay is one of the founders of the American Society of Gene Therapy and served as its President in 2005-2006.
Human Genetics. The Vanderbilt Human Genetics PhD program (HGEN) has served as a model of successful interdisciplinary biomedical research to graduate students since its inception. Genetics is the study of variation in and transmission of hereditary material from generation to generation and how this information is translated into biological function.
The graduate program in Human Genetics is the home within the Division of Biological Sciences for the study of basic principles of genetics and genomics as applied to human phenotypes. We provide broad training in experimental and computational genetics and genomics, statistical and population genetics, bioinformatics, and clinical genetics.
UNC Department of Genetics. We advance fundamental, translational, and clinical research in genetics and genomics through innovation, education, and collaboration. Our graduate programs train students to be creative, sophisticated research scientists prepared to pursue careers focused in genetics and genomics working in academic science ...
PhD Training Program. The program in Genetics and Development provides a broad, solid education in genetics and animal development, with rigorous training in critical thinking and experimental design. Genetics is central to all of biology and the training program is guided by the principle that understanding the genetic control of development ...
Congratulations to PhD candidate, Ari from the Dr. Singh lab, for being selected to receive the Spring 2024 GGSA Conference Award! Ari received this award for attending the Texas Genetics Society (TGS) 2024 in College Station, TX from March 21-23, 2024, where he had the opportunity to present his project titled 'Consequences of IPA isoform ...
Why Study Genetics in United States. Studying Genetics in United States is a great choice, as there are 48 universities that offer PhD degrees on our portal. Over 957,000 international students choose United States for their studies, which suggests you'll enjoy a vibrant and culturally diverse learning experience and make friends from all ...
The program objectives are delineated below. By graduation, a Genetics & Genomics PhD student will: Generate an original body of work in the biomedical sciences that reflects critical thinking and independent thought. Demonstrate competencies in advanced research skills and critical thinking.
The University of Iowa, based in Iowa City, IA, offers a fully funded PhD in Genetics. The interdisciplinary PhD program trains students on the frontiers of Genetics research and develops leaders that meet the upcoming challenges in the field of Genetics. Students in the Interdisciplinary Graduate Program in Genetics are eligible for financial ...
Shaobo Qin will present her dissertation research on 7/29. Courtney Tello earns an NIH/NIGMS F31 fellowship. Xiao Han receives an NIH/NCI F99/K00 fellowship. Qingting Hu and Joanne Saldanha receive Mow Shiah Lin scholarships. Welcome to the Genetics 2023 entering class! Steven Lewis and Lucia Yang receive NIH/NCI fellowships.
The nationally ranked Genetics, Development and Disease Graduate Program combines biology with the latest technology to enable researchers to delve into the genetic, molecular, and developmental mechanisms underlying basic biology and disease. The Program attracts scientists who are dedicated to pushing the boundaries of DNA research and making ...
From crop-based biofuels to pest-resistant plants, discoveries of plant scientists make a profound impact on the world's food production, natural resources and the environment. This program prepares you to make your own contribution to this exciting field through the in-depth study of the production, protection, breeding and genetics of plants.
Grade Point Average: In general, the MS in Genetic Counseling Program expects its applicants to have maintained an undergraduate average of "B" or better (GPA of 3.3) in science and humanities. NOTE: The most recently admitted PhD and MS graduate education classes at WCGS had an average overall GPA of 3.6 and an average science GPA of 3.6.
A particular program may or may not require a master's degree as a prerequisite for the qualifying evaluation. As soon as the program's qualifications are met, a supervisory committee is appointed. Preparation of Study Plan. Refer to "Preparation and Submission of Study Plan" in the preceding General Graduate Regulations section.
PhD in Molecular Biology, DSci in Genetics, Moscow State University, Moscow, Russia. ... The strongest aspect of my research program lies in its transdisciplinary nature. In over more than twenty years of active time in academia, I have developed an expertise in a variety of research fields. In many collaborations, I analyze multidimensional ...
Doctoral Programs. PhD or Doctor of Science degrees are conferred by the Dissertation Committee further to the results of the public thesis defence. 30 Dissertation Committees on PhD and doctoral thesis defence work at RUDN University. These committees have ensured senior scholars' training on 16 fields of study and 64 scientific specialities ...
Chelsea Powell, M.D., is a general surgery resident at Mayo Clinic School of Graduate Medical Education.She's also one of the first five matriculants in the graduate school's newly established Clinician-Scientist Academic Research Excellence Ph.D. (CARE Ph.D.) program. Through the program, residents and fellows can pause their clinical training to pursue graduate-level studies in biomedical ...